Stanford
http://www.stanfordgroup.com/#Stanford provides institutional investment services and private wealth management services. The firm also offers equity research to its clients in the consumer, media, energy, financial, healthcare, technology and water/environment sectors.
View Older Stories View More Recent Stories
-
SkyWater Technology (SKYT) Appoints Nancy Fares and Amy Leong to its Board
-
Kiora Pharmaceuticals (KPRX) Appoints David Hollander to its Board
-
Toll Brothers (TOL) Appoints Derek T. Kan to its Board
-
Duoling (DUOL) Names John Lilly to Board
-
Duoling (DUOL) Appoints John Lilly to its Board
-
Edwards Lifesciences (EW) sees 2022 adjusted earnings per share $2.50 - $2.65
-
Stanford Health Care Named Top Teaching Hospital by Leapfrog Group
-
Petco Health and Wellness (WOOF) Appoints Iris Yen as Board Advisor and Observer
-
Advance Technologies Inc (AVTX) Appoints June Almenoff and Mitchell Chan to its Board
-
Lyft (LYFT) Appoints Elaine Paul as CFO
-
C3.ai (AI) Reports Q2 Revenues of $58.3M, Non-GAAP EPS of $(0.23)
-
Vertex Pharma (VRTX) Announces Positive Results From Phase 2 Study of VX-147 in APOL1-Mediated Focal Segmental Glomerulosclerosis
-
23andMe Holding Co. (ME) Appoints Joseph R. Arron as Chief Scientific Officer
-
Cybin Inc (CYBN) Announces FDA Approves a Co-Funded Phase 2 Clinical Trial to Treat Frontline Clinicians Experiencing COVID-Related Distress
-
Stanford University Partners with Kheiron Medical Technologies to Pioneer Use of AI in New Areas of Oncology
-
Krystal Biotech (KRYS) Announces Positive Topline Results from GEM-3 Pivotal Trial of VYJUVEK in Patients with Dystrophic Epidermolysis Bullosa
-
ResMed (RMD) Appoints Desney Tan and John Hernandez to Its Board
-
Stanford Scientists First To Identify New Cellular Correlates of Protection Against Influenza for an Oral Flu Vaccine Developed by Vaxart
-
Sarepta Therapeutics (SRPT) Appoints Stephen L. Mayo to its Board
-
Taylor Morrison Home (TMHC) Appoints Christopher Yip to its Board
-
Kala Pharmaceuticals (KALA) Acquires Combangio
-
Talkspace (TALK) Awarded $3 Million Federal Grant to Study Groundbreaking Treatment for PTSD
-
Urban Affairs Coalition Announces Service Award Honorees in Celebration of 52 Years of Positive Community Impact
-
Heritage Financial (HFWA) Appoints Trevor Dryer and Gail Giacobbe to its Board
-
Myovant Sciences (MYOV) Appoints Nancy Valente to its Board
-
Omeros (OMER) Announces Results From Nearly Three-Year Follow-up of Patients in Phase 2 IgA Nephropathy Trial
-
Cognex Corp (CGNX) Appoints Marjorie T. Sennett to its Board
-
OneSpaWorld (OSW) and F45 Training (FXLV) Bring First F45 Studio on Board Celebrity Cruises
-
Quoin Pharmaceuticals Ltd (QNRX) Appoints Gordon Dunn as CFO
-
Beyond Air, Inc. (XAIR) Separates Cancer Business into Beyond Cancer
-
Robinhood (HOOD) announces way to facilitate meaningful, community-driven access to IPOs
-
89bio Inc. (ETNB) Announces Appointment of Kathy LaPorte to its Board of Directors
-
Stanford Medicine Earns Top Ranking for Quality, Safety From Vizient
-
F45 Training Holdings Inc. (FXLV) Announces Partnership with Royal Caribbean
-
ClearPoint Neuro Inc. (CLPT) Appoints Linda M. Liau to its Board
-
BridgeBio Pharma Inc. (BBIO) Collaborates with Columbia University and Mount Sinai to Develop Potential Therapies for Genetic Diseases and Cancers
-
BridgeBio Pharma Inc. (BBIO) Appoints Hannah Valantine to its Boar
-
Frontdoor, Inc. (FTDR) Appoints Christopher Clipper to its Board
-
urban-gro Inc. (UGRO) Appoints Sonia Lo to its Board
-
Wine.com Adds Industry Veterans to Merchandising Team to Support Growth
-
Wine.com Adds Industry Veterans to Merchandising Team to Support Growth
-
SpringWorks Therapeutics (SWTX) to Collaborate with Leading Academic Institutions to Advance Portfolio of Next-Generation Mutation-Selective EGFR Inhibitors
-
Altra Industrial Motion (AIMC) Appoints La Vonda Williams to its Board
-
TG Therapeutics (TGTX) Announces Data for Ublituximab in MS Presented at ECTRIMS
-
Sunnova Energy International Inc. (NOVA) Appoints Mary Yang to Its Board
-
TRACON Pharmaceutical (TCON) Appoints Carol Lam to its Board
-
Dyne Therapeutics Inc. (DYN) Highlights Preclinical Data and Clinical Development Plans for DMD and DM1 Programs
-
Spero Therapeutics (SPRO) Appoints Kathleen Tregoning to its Board
-
BridgeBio Pharma (BBIO) Announces Progress in its KRAS Portfolio, New Gene Therapy Programs, and Updates on Advancements Across its R&D Pipeline
-
PPL Corp. (PPL) Appoints Heather B. Redman to its Board

